Review Article
Treatment of Hepatitis B in Decompensated Liver Cirrhosis
Table 3
Antiviral Agents with Activity against Wild Type and Lamivudine resistant HBV.
| Agent | Daily dose | Side effects | Comments |
| Adefovir | 10 mg | Dose-dependant nephrotoxicity | Drug resistance after 12 months | Entecavir | 1 mg | No major side effects to date | Drug resistance eventually in lamivudine-resistant mutants | Tenofovir | 300 mg | Neuropathy, nausea, CPK elevations, Fanconi syndrome | No drug resistance up to 4 years |
|
|